![](/img/cover-not-exists.png)
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
Ahmad A. Tarhini, Michael Millward, Paul Mainwaring, Richard Kefford, Ted Logan, Anna Pavlick, Steven J. Kathman, Kevin H. Laubscher, Mohammed M. Dar, John M. KirkwoodVolume:
115
Year:
2009
Language:
english
Pages:
10
DOI:
10.1002/cncr.24100
File:
PDF, 140 KB
english, 2009